PR Newswire Asia's news > Medical Equipment

 < Previous page   |   Title only   |   Print    Next page > 
     
ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights
The ZEISS CLINIC 360 all-in-one browser-based software solution aggregates clinical data at scale and powers advanced analytics for streamlined ophthalmic workflows, providing clinicians with more time ...
2026-08-19T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first half of 2026. During the reporting period, ...
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
So-Young to Report Second Quarter 2026 Financial Results on August 31, 2026
BEIJING , Aug. 19, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers ...
2026-08-19T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics   Medical Equipment 
NORROY BIOSCIENCE Granted FDA Breakthrough Therapy and Fast Track Designations for Kidney Cancer Imaging Product
WUXI, China , Aug. 19, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY) , a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that the U.S. Food and ...
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma
Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 Blenrep, a first-in-class anti-BCMA ADC, could transform treatment ...
2026-08-19T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
/C O R R E C T I O N -- Rayence/
In the news release, Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V', issued 18-Aug-2026 by Rayence ...
2026-08-19T    Computer Software   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Enginprime Medical Closes $12M Series A Financing
Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development ...
2026-08-18T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
VANCOUVER, BC , Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The ...
2026-08-17T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
CAMBRIDGE, Mass. , Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI) , announced ...
2026-08-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia
New 316,000-square-foot facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032 ...
2026-08-17T    Health Care/Hospital   Medical Equipment 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.